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Lipophilic bisphosphonium salts are among the most promising antiprotozoal leads currently under
investigation. As part of their preclinical evaluation we here report on their mode of action against Af-
rican trypanosomes, the etiological agents of sleeping sickness. The bisphosphonium compounds CD38
and AHI-9 exhibited rapid inhibition of Trypanosoma brucei growth, apparently the result of cell cycle
arrest that blocked the replication of mitochondrial DNA, contained in the kinetoplast, thereby pre-
venting the initiation of S-phase. Incubation with either compound led to a rapid reduction in mito-
chondrial membrane potential, and ATP levels decreased by approximately 50% within 1 h. Between 4
and 8 h, cellular calcium levels increased, consistent with release from the depolarized mitochondria.
Within the mitochondria, the Succinate Dehydrogenase complex (SDH) was investigated as a target for
bisphosphonium salts, but while its subunit 1 (SDH1) was present at low levels in the bloodstream form
trypanosomes, the assembled complex was hardly detectable. RNAi knockdown of the SDH1 subunit
produced no growth phenotype, either in bloodstream or in the procyclic (insect) forms and we conclude
that in trypanosomes SDH is not the target for bisphosphonium salts. Instead, the compounds inhibited
ATP production in intact mitochondria, as well as the puriﬁed F1 ATPase, to a level that was similar to
1 mM azide. Co-incubation with azide and bisphosphonium compounds did not inhibit ATPase activity
more than either product alone. The results show that, in T. brucei, bisphosphonium compounds do not
principally act on succinate dehydrogenase but on the mitochondrial FoF1 ATPase.
© 2015 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
African trypanosomes are responsible for a spectrum of impor-
tant human and veterinary diseases south of the Sahara, trans-
mitted by various tsetse ﬂy species. Trypanosoma brucei gambiense
causes a chronic but fatal human African trypanosomiasis (HAT, orunity and Inﬂammation, Col-
ty of Glasgow, 120 University
Biology Centre & Faculty of
ice 37005, Czech Republic.
Harry.de-Koning@glasgow.ac.
of Science, Aljouf University,
Ltd on behalf of Australian Society fsleeping sickness) in Western and Central Africa, whereas T. b.
rhodesiense causes a much more acute illness in Eastern and
Southern Africa (Brun et al., 2010); both forms of the disease are
considered almost invariably fatal if left untreated. Whereas
transmission of T. b. gambiense appears to be almost exclusively
anthroponotic, T. b. rhodesiense is a zoonotic parasite, with many
wild and domestic animals, particularly cattle, acting as reservoirs
(Welburn et al., 2001). In addition, Trypanosoma congolense, T. b.
brucei, Trypanosoma evansi and Trypanosoma vivax cause animal
African trypanosomiasis (AAT), inﬂicting a terrible burden on
agriculture in the tsetse belt and, for the latter two species, also in
areas far beyond the testse habitat including the Indian subconti-
nent and South America (Desquesnes et al., 2013; Osorio et al.,
2008; Swallow, 1999).
While vector control in conjunction with extensive surveillance
can have highly signiﬁcant local impact on the disease burden,
there is no realistic prospect of a vaccine (La Greca and Magez,or Parasitology. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Benzophenone-derived bisphosphonium salts used in this study.
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(Delespaux and de Koning, 2007; Jannin and Cattand, 2004).
However, few drugs currently exist for either HAT or AAT, and these
are old, suffer from severe side-effects and/or resistance, and are
usually only effective against certain (sub) species or stages of the
disease (Brun et al., 2010; Delespaux and de Koning, 2007). New
therapeutic agents are therefore urgently necessary, preferably
active against all African trypanosome species, and against both
stages of the human disease. One promising lead is the class of
benzyltriphenylphosphonium compounds that displays highly
potent activity against rodent models of T. b. rhodesiense
(Kinnamon et al., 1979), Trypanosoma cruzi (Kinnamon et al., 1977)
and Leishmania donovani (Hanson et al., 1977) infections. Moreover,
a large series of bisphosphonium salts were shown to possess
strong anti-leishmanial (Luque-Ortega et al., 2010) and trypanoci-
dal (Dardonville et al., 2015; Taladriz et al., 2012) activity in vitro.
Many of these compounds showed high selectivity against the
kinetoplastid parasites relative to human cell lines and, impor-
tantly, displayed no cross-resistance with existing trypanocides
such as diamidines and melaminophenyl arsenicals (Taladriz et al.,
2012).
The triphenylphosphonium (TPP) moiety has been used exten-
sively as a vehicle to deliver drugs to mitochondrial targets (Cairns
et al., 2015; Cortes et al., 2015; Smith et al., 2011). Among many
applications, TPP has been used to deliver functional probes (Cairns
et al., 2015), antioxidants (Kelso et al., 2001; Teixeira et al., 2012),
anti-cancer drugs (Jara et al., 2014), and even liposomes (Benein
et al., 2015) to mitochondria. TPP-linked natural compounds
botulin and betulinic acid showed in vitro and in vivo activity
against Schistosoma mansoni (Spivak et al., 2014). Crucially, TPP-
mediated mitochondrial targeting appears to be generally safe, as
a double-blind, placebo controlled study with human volunteers
found no evidence of side-effects of the TPP-coupled antioxidant
MitoQ over a 12-month period (Snow et al., 2010).
The mitochondrial accumulation of TPP-coupled drugs is driven
by the strong inside-negative potential across the inner membrane
of the mitochondrion. TPP, being a lipophilic cation with a highly
dispersed charge is believed to diffuse freely across the inner
membrane and be highly concentrated in themitochondrial matrix,
to an extent determined by the mitochondrial membrane potential
Jm and the plasma membrane potential Vm, as described by the
Nernst equation (Cairns et al., 2015). Consistent with the extensive
TPP literature, Luque-Ortega et al. showed that the anti-leishmanial
TPP analogues targeted the parasite's mitochondrion, and proposed
their principal action to be the inhibition of the succinate dehy-
drogenase complex (complex II) (Luque-Ortega et al., 2010). How-
ever, similar compounds also had strong activity against
bloodstream form (BF) T. brucei (Dardonville et al., 2015; Taladriz
et al., 2012), which has a much less elaborate mitochondrial
metabolism, lacking for instance much of the Krebs cycle, and the
cytochrome-dependent respiratory chain (Tielens and van
Hellemond, 2009). Transfer of electrons to oxygen is instead
mediated by a plant-like alternative oxidase (Chaudhuri et al., 1998)
and the mitochondrial membrane potential is maintained by the
FoF1 ATPase pumping protons from the mitochondrial matrix
(Nolan and Voorheis, 1992; Schnaufer et al., 2005). We thus
investigated whether the succinate dehydrogenase complex is
expressed in BF T. brucei, and whether this might be the primary
target for the trypanocidal activity of triphenylphosphonium salts
and their analogues. We selected two compounds with strong
trypanocidal activity (Taladriz et al., 2012) to represent the main
two classes of aliphatic and aromatic bisphosphonium salts (Fig. 1).2. Materials and methods
2.1. Effect of bisphosphonium compounds on growth of BF T. brucei
The effects of AHI-9 and CD38 on growth of BF Trypanosoma
brucei brucei strain Lister 427 were investigated by incubating
cultures under standard conditions (HMI-9/10% FBS; 37 C, 5% CO2)
in the presence or absence of 0.1 mM, 0.3 mMor 1 mM test compound
for up to 72 h. Samples were taken in triplicate at the following
times (h) after initiation of the experiment: 0, 4, 8, 12, 24, 28, 32, 36,
48, 52, 56, 60, 72. Cell density in the samples was determined using
a haemocytometer. Compounds CD38 and AHI-9 were synthesized
as reported previously (Luque-Ortega et al., 2010; Taladriz et al.,
2012).2.2. Determination of trypanocidal action using the Alamar blue
assay
Fifty percent effective concentrations (EC50) were determined
using the ﬂuorescence viability indicator dye Alamar Blue (resa-
zurin sodium salt, Sigma), exactly as described (Gould et al., 2013,
2008). Serial doubling dilutions of test compounds were prepared
over two rows of a 96-well plate, leaving the last well without
added drug as a control, before the addition of an equal volume of
cell suspension to each well. Final cell density in each well was 105
BF T. brucei per mL. The plates were incubated for 48 h (37 C, 5%
CO2) before the addition of 20 mL resazurin solution (125 mg/mL in
PBS pH7.4) per well and incubation for a further 24 h. Fluorescence
was determined using a FLUOstar Optima (BMG Labtech, Durham,
NC, USA) with excitationwavelength set at 544 nm and emission at
620 nm. Data were plotted to a sigmoid curve with variable slope
using Prism 5.0 (GraphPad, San Diego, CA).2.3. Assessing cell cycle progression in T. brucei
2.3.1. DAPI staining
Nuclei and kinetoplasts were visualized using the ﬂuorescent
dye 4,6-diamidino-2-phenylindole (DAPI) on BF trypanosomes af-
ter ﬁxation. 50 mL of cells at ~5  105 cells/mL were spread onto a
glass microscope slide, left to air dry and ﬁxed in methanol over-
night at 20 C. The slides were rehydrated with 1 mL of PBS for
10 min, which was allowed to evaporate (but not to completely
dry). 50 mL of PBS containing 1 mg/mL DAPI and 1% of 1,4-
diazabicyclo [2.2.2] octane (DAPCO) was added to the slides and
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Axioplan microscope using a Hamamatso digital camera and
Openlab software. 500 cells were recorded for each sample, and
scored for DNA conﬁguration into the following groups: 1N1K,
1N2K, 2N2K (Early) and 2N2K (Late) (N, nucleus; K, kinetoplast;
‘Early’ no ingression furrow; ‘Late’, cell division started with clear
ingression furrow). The effect of test compounds on DNA conﬁgu-
ration was determined at 0, 8, 12, 16 and 24 h; untreated cultures
served as control.
2.3.2. Flow cytometry
DNA content of BF trypanosomes was measured by ﬂow
cytometry using the ﬂuorescent dye propidium iodide (PI), as
described (Hammarton et al., 2003; Ibrahim et al., 2011). Brieﬂy,
1 mL of cell suspension at 106 cells/mL was transferred at each time
point into microfuge tubes and centrifuged at 2500 rpm for
10min at 4 C, then resuspended and ﬁxed in 1mL of 70%methanol
and 30% PBS and left at 4 C overnight. The samples were washed
twice with 1 mL of PBS and subsequently resuspended in 1 mL PBS
containing propidium iodide and RNase A (both at 10 mg/mL), and
incubated at 37 C for 45 min while protected from light. Samples
were analysed by Becton Dickinson FACSCalibur using the FL2-Area
detector and CellQuest software. ModFit LT software was used to
quantify the ﬂow cytometry results.
2.4. Measuring intracellular calcium in BF T. brucei
Intracellular calcium levels were measured using the Screen
Quest™ Fluo-8 Calcium Kit (ABD Bioquest, Sunnyvale, CA). T. b.
brucei of strain Lister 427were grown in HMI-9/FCS in vented ﬂasks
incubated (37 C/5% CO2 for 48 h) and harvested by centrifugation
(2500  g, 10 min at 4 C), resuspended to a ﬁnal density of
4  106 cells/mL and divided into aliquots for determination at 0, 4,
8,12 h of exposure to test compounds (in HMI-9/FCS, 37 C/5% CO2).
At an appropriate interval before the start of the measurement,
aliquots of this culture were transferred to centrifuge tubes,
centrifuged (10 min, 2500 g) and resuspended in the Fluo-8 dye-
loading solution at exactly 4 106 cells/mL and further incubated at
37 C for 30 min. The cells were then washed twice with assay
buffer to remove any extracellular dye-loading solution. 90 mL of
cell suspensionwas added to eachwell of a black-bottomed 96-well
plate, and subsequently 10 mL of test compound at
10  concentration was added (except for the 0 min recording);
10 mM calcium ionophore A23187 (Sigma) was used as a positive
control and 10 mL buffer was added to a well that served as drug-
free control. The plate was then incubated in a FLUOstar OPTIMA
ﬂuorimeter at 37 C, and the ﬂuorescence was observed for 10 min
using cycles of 4 s.
2.5. Mitochondrial membrane potential of BF T. brucei
2.5.1. Analysis of drug-treated cells
The mitochondrial membrane potential of treated and un-
treated cells was assessed by using Tetramethylrhodamine ethyl
ester (TMRE) (Denninger et al., 2007; Figarella et al., 2006). The cell
density was adjusted to 106 cells/mL with and without test com-
pounds for the start of the experiment. 1 mL of sample was trans-
ferred at each time point into a microfuge tube and centrifuged at
2500 rpm for 10min at 4 C, and was then resuspended in 1 mL PBS
containing 25 nM of TMRE, and cells were incubated at 37 C for
30 min. Valinomycin (100 nM) and troglitazone (10 mM) were used
as controls, as they are known to induce mitochondrial membrane
depolarization and hyperpolarization, respectively (Denninger
et al., 2007). All samples were analysed by ﬂow cytometry using
a FL2-heigth detector and CellQuest software. Mitochondrialmembrane potential was expressed as the percentage of cells dis-
playing ﬂuorescence higher than 100 artiﬁcial units, which was
calibrated at exactly 50% for the no-drug control sample of the zero
incubation time point, as described (Ibrahim et al., 2011).
2.5.2. Analysis of RNAi cell lines
Cells in the exponential growth phase were stained with 60 nM
of TMRE for 30 min at 37 C. Cells were pelleted (1300  g, 10 min,
RT), resuspended in 2 mL of PBS (pH 7.4) and immediately analysed
by ﬂow cytometry (BD FACS Canto II Instrument). For each sample,
10,000 events were collected. Treatment with the protonophore
FCCP (20 mM) was used as a control for mitochondrial membrane
depolarization. Data were evaluated using BD FACSDiva (BD Com-
pany) software.
2.6. Plasmid construction, transfection, cell growth and RNAi
induction
To create the SDH1 (Tb927.8.6580) RNAi construct, a 485 bp
fragment was PCR ampliﬁed from T. brucei strain 427 genomic DNA
with the following oligonucleotides: FW: GAT GGA TCC CTC TGG
GCT TCG TGC CGC AA, REV: GGA AAG CTT TGC CAC GAC AAC AGC
CGT CC utilizing the respective BamHI and HindIII restriction sites
inherent in the primers (underlined). The digested amplicon was
then cloned into the p2T7-177 plasmid (Wickstead et al., 2002).
This plasmid was used for transfection of PF T. brucei Lister 427
29.13 and BF Lister 427 single marker (SM) T. brucei cells that are
transgenic for the T7 RNA polymerase and the tetracyclin (tet)
repressor (Wirtz et al., 1999). PF 29.13 cells were grown in vitro at
27 C in SDM79 medium containing hemin (7.5 mg/mL), hygrom-
ycin (25 mg/mL), G-418 (10 mg/mL) and 10% foetal bovine serum. BF
SM cells were grown in vitro at 37 C in HMI-9 medium containing
G-418 (2.5 mg/mL) and 10% foetal bovine serum. After the trans-
fection, both cell lines were selected using phleomycin (2.5 mg/mL).
The inducible expression of double-stranded RNAwas triggered by
the addition of 1 mg/mL tetracycline to the medium. Growth curves
were generated by measuring the cell density of tet-treated and
untreated cultures using the Z2 cell counter (Beckman Coulter Inc.).
Throughout the experiment, PF and BF cultures were split daily to
ensure they continuously maintained an exponential growth phase
of 106 - 107 cells/mL and 105e106 cells/mL, respectively.
2.7. Electrophoresis and western blot analysis
Crude mitochondrial fraction was isolated as described previ-
ously (Koreny et al., 2012; Subrtova et al., 2015) and the mito-
chondria were lysed using digitonin at detergent:protein ratio of
4 mg:1 mg. High resolution clear native (hrCN) PAGE analysis was
performed by fractionating 50 mg of mitochondrial lysate on a
3e12% clear native (CN) PAGE gel followed by a protein transfer
onto a nitrocellulose membrane. Protein samples from mitochon-
drial lysates were also separated on SDS PAGE gels and blotted onto
a PVDFmembrane. Bothmembranes were incubatedwith a speciﬁc
SDH1 peptide antibody (1:1000) (Koreny et al., 2012), followed by
an incubation with a secondary HRP-conjugated anti-rabbit anti-
body (1:2000, BioRad). The speciﬁc reaction was visualized using
the Clarity™ Western ECl Substrate (Biorad) on a ChemiDoc in-
strument (BioRad).
2.8. Succinate:ubiquinone reductase (SQR) activity assay
The speciﬁc SQR activity wasmeasured in a crudemitochondrial
preparation ð15mgÞ in 1 mL of SDH buffer (25 mM K2HPO4, pH 7.2,
5 mM MgCl2, 20 mM sodium succinate) containing speciﬁc in-
hibitors of respiratory complexes III and IV (0.0002% antimycin,
Table 1
EC50 values for CD38 and AHI-9 compounds against BF427 and PF427 T. brucei cells.
EC50 CD38 [mM] EC50 AHI-9 [mM]
T. brucei BF427 0.52 ± 0.038 0.14 ± 0.016
T. brucei PF427 3.54 ± 0.14 1.19 ± 0.08
P value 0.00003 0.00004
The values represent the average and SEM of three independent determinations.
The P value given is of an unpaired Student's t-test comparing the EC50 values for BF
and PF trypanosomes.
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(Sigma)), which acts as the electron acceptor. The reaction was
started by adding 65 mM coenzyme Q2. The unit of succina-
teedehydrogenase activity (U) is deﬁned as an amount of enzyme
in 1 mg of kinetoplastid proteins, which causes the conversion of
1 nmol of DCIP in 1min, asmonitored at 600 nm (Birch-Machin and
Turnbull, 2001).
2.9. F1-ATPase puriﬁcation
Mitochondrial vesicles were puriﬁed as described previously
(Acestor et al., 2011). Afterwards theywere resuspended in buffer A
(0.25 M sucrose, 50 mM TriseHCl pH 8, 1 mM DTT) and the sus-
pensionwas sonicated on power 8.5 for 3 40 s, with an incubation
on ice of 1 min between sonications to prevent heating the sample.
The samples were further sonicated for 10 15-s bursts, again left on
ice for 1 min between the sonications (Sonicator 3000, Misonix,
19 mm probe, 250 W). The submitochondrial particles were then
pelleted overnight in a SW60Ti rotor at 52,000 g at 4 C.
The SMP pellet was resuspended in buffer B (0.25 M sucrose,
50 mM Tris HCl pH 8.0, 1 mM DTT, 4 mM EDTA, 2 mM ADP).
Chloroform, saturated with 2 M TriseHCl pH 8.5, was added to the
pellet and then vigorously shaken for 20 s followed by immediate
centrifugation for 5 min at 8500 rpm at room temperature. The top
(light brown) layer was taken, leaving the middle (dark brown) and
the bottom (chloroform containing) layers behind. The F1 depleted
SMPs and residual chloroformwere removed by centrifugation in a
SW28 rotor at 27,000 rpm for 30 min at room temperature, using
chloroform resistant polyallomer tubes. The F1-ATPase containing
supernatant was carefully removed to avoid any chloroform
contamination, blownwith nitrogen for 15 min to remove all traces
of chloroform. The F1-ATPase was ﬁltered, concentrated down to
750 ml and loaded on a Superdex 200 10/300 GL. The F1-ATPase was
puriﬁed on a FPLC using a speciﬁc F1-column buffer (20 mM Tris pH
8.5, 200 mM NaCl, 1 mM DTT, 4 mM EDTA, 1 mM ADP, 0.002%
PMSF).
2.10. ATPase activity measurements
The amount of ATP hydrolysis in a crude mitochondrial prepa-
ration or by afﬁnity puriﬁed F1 ATPase was measured by ATP
regenerating assay (Pullman et al., 1960) that couples the hydrolysis
of ATP with the oxidation of NADH. Crude mitochondrial lysates
(15 mg) or puriﬁed F1 ATPase (0.7 mg) were incubated with different
concentrations (5e200 mM) of CD38 and AHI-9 for 5 min after
which the mix was transferred to a 1-mL UV cuvette containing an
ATPase buffer (50 mM Tris, pH 8, 50 mM KCl, 2 mMMgSO4, 200 mM
NADH, 1 mM phosphoenol pyruvate, 5 mL of lactate dehydrogenase
(Sigma) and 9 mL of pyruvate kinase (Sigma)). The reactionwas then
initiated by adding 2 mM MgATP (from 100 solution of 400 mM
Tris, 200mMMgSO4, 200mMATP) and the change of absorbance at
340 nm was measured for 5 min. Azide (1 mM) was used as a
known inhibitor of F1 ATPase activity (Bowler et al., 2006). Speciﬁc
ATPase activity of mitochondrial lysate or of puriﬁed F1 ATPase was
calculated from the amount of NADH oxidized in 1 min, and nor-
malised to the amount of the protein in the sample.
2.11. ATP production
ATP production in digitonin-extracted mitochondria was
measured following a protocol described previously (Allemann and
Schneider, 2000). Brieﬂy, crude mitochondrial fractions from the
RNAi knockdown cell lines were obtained by digitonin extraction
(Tan et al., 2002). ATP production in these samples was induced by
the addition of 67 mM ADP and 5 mM of succinate. Themitochondrial preparations were preincubated for 10 min on ice
with the inhibitors malonate (6.7 mM) and atractyloside (33 mg/
mL). The concentration of ATP was determined by a luminometer
(Orion II, Berthold detection systems) using the CLS I ATP biolu-
minescence assay kit (Roche Applied Science).
2.12. Surface plasmon resonance (SPR)
SPR experiments were performed at 25 C with a Biacore X100
apparatus (GE Healthcare, Biacore AB, Uppsala, Sweden) in MES
buffer (10 mM 2-(N-morpholino)ethanesulfonic acid, 1 mM EDTA,
100 mM NaCl, 0.005% surfactant P20, pH 6.25). The 50-biotin
labelled DNA hairpins 50-CGAATTCGTCTCCGAATTCG-30 and 50-
CGCGCGCGTTTTCGCGCGCG-30 (the loop is underlined) were pur-
chased from SigmaeAldrich with HPLC puriﬁcation. The SPR
measurements were carried out as described (Rios Martinez et al.,
2014).
3. Results
3.1. Actions of bisphosphonium compounds on T. brucei growth and
cell cycle
We investigated the actions of two bisphosphonium compounds
on bloodstream form (BF) T. b. brucei. The compounds CD38 and
AHI-9 were selected as (i) displaying sub-micromolar activity
against the parasite, (ii) possessing >300-fold in vitro selectivity
with a human cell line and (iii) representing the twomain classes of
phosphonium trypanocides, possessing either linear saturated
aliphatic substituents (n-pentyl; CD38) or aromatic substituents
(phenyl and 3-methylphenyl; AHI-9) on the phosphonium moiety
(Taladriz et al., 2012).
Both compounds were conﬁrmed to be active against T. brucei,
with sub-micromolar activity against BF cells and about an order of
magnitude less activity against the procyclic forms (PF) (Table 1). At
concentrations up to the EC50 values the compounds caused
delayed growth rather than cell death and even at concentrations
several fold above EC50 (1 mM) the initial effect appeared to be
immediate (CD38) or slightly delayed (AHI9) growth arrest, fol-
lowed by cell death 16e24 h later (Fig. 2). We thus investigated
whether the compounds induced cell cycle arrest in a speciﬁc phase
of the cycle, using ﬂow cytometry to measure the DNA content in
single cells of the population. As expected, we found that untreated
control cells were less prone to enter S-phase when the culture
entered the late log-phase of growth, leading to a small increase in
G1-phase cells after 16 h; the proportion of G1-phase cells had
initially decreased as the culture progressed from stationary to
early log phase; the proportion of cells in S-phase steadily declined
during late log phase (Fig. 3A). Similar effects, but much more
pronounced and at much lower cell densities, were observed in the
cultures treated with CD38 or AHI-9: both displayed a steep decline
in S-phase cells after 8 h, accompanied by a signiﬁcant increase in
G1-phase cells (Fig. 3A, B), although the cultures were in virtual
growth arrest and at comparatively low density (Fig. 3C). We thus
Fig. 2. Effect of different concentrations of two bisphosphonium compounds on the growth of BF T. brucei brucei over 72 h. Cell cultures were seeded at 105 cells/mL. Microscopic
cell counts were performed in triplicate using a haemocytometer at various time points as indicated. The results shown are the average of three independent determinations; error
bars depict standard errors.
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from entering the cell cycle and initiating DNA synthesis.
CD38 also caused a highly signiﬁcant decrease in cells in the ﬁrst
stages of trypanosomal cell division, i.e. with 1 nucleus and 2 ki-
netoplasts (1N2K), or with 2 of each (2N2K) but no cleavage furrow
initiated (2N2K-Early), after 8 h of treatment; the percentage of
cells in all stages of division (IN2K, 2N2K) continued to decline
sharply with the exposure time (Fig. 3D), as no new cells entered
the cell division cycle. This experiment showed that
bisphosphonium-treated cells were unable to replicate kinetoplast
DNA and/or initiate kinetoplast division. It was not possible to
reliably distinguish between the two possibilities, although we did
not observe increased DAPI ﬂuorescence associated with the
kinetoplast (i.e. kDNA content) after CD38 treatment (not shown);
however, it is uncertain whether this would have been sufﬁciently
unambiguous. However, it has previously been reported that CD38
does not bind directly to a poly(dA.dT)2 DNA polymer (Dardonville
et al., 2006), and we here follow that up with SPR measurements of
CD38 and AHI-9 binding to two other DNA. Neither compound
showed measurable binding to the CGAATTCG oligonucleotide, and
only CD38 interacted, weakly, with the CGCGCGCG sequence, with
a KD of 7.0  106 M (Supplementary Fig. S1). This seems incon-
sistent with a direct action on kinetoplast replication by kDNA
binding.
3.2. The mitochondrion as a target for the trypanocidal activity of
bisphosphonium salts
It has been reported that CD38 elicits anti-leishmanial activity
by inhibiting the succinate dehydrogenase complex (also known as
complex II) in the L. donovani mitochondrion (Luque-Ortega et al.,
2010), and a mitochondrial target would be consistent with the
observed phenotype of being unable to initiate kinetoplast division
(above).
Incubation of BF T. brucei with CD38 or AHI-9 for 4 h, at con-
centrations close to their respective EC50 values, caused a dose-
dependent reduction of the mitochondrial membrane potential
Jm (Fig. 4A). At 0.7 mM bisphosphonium compound, small effects
were observed after just 30min (P < 0.05 for CD38) andmuchmore
dramatic reductions were seen after 4 h of exposure (P < 0.001 for
both compounds) until the mitochondrial membranes appeared to
be almost fully depolarized (Fig. 4B). This was accompanied by asimilar drop in cellular ATP levels, which was highly signiﬁcantly
different from control (P < 0.01) and was statistically identical to
treatment with the F1Fo ATPase inhibitor oligomycin after 1 h. This
level of cellular ATP remained essentially constant for at least 12 h
of treatment with either of the test compounds (Fig. 4C). The
decrease of cellular ATP is in agreement with the observed redi-
rection of glycolysis to 1 molecule of glycerol and 1 molecule of
pyruvate due to Jm dissipation (see the discussion). Another
cellular effect was that after four hours of incubation with CD38 or
AHI-9 the level of free intracellular Ca2þ started to increase
(Fig. 4D), which was consistent with the depolarized mitochondria
being unable tomaintain their capacity as calcium reservoir (Huang
et al., 2013).
3.3. Assessment of succinate dehydrogenase as a potential target for
bisphosphonium compounds in T. brucei
Because the target of bisphosphonium salts in L. donovani cells
was suggested to be the succinate dehydrogenase (SDH) complex
(Luque-Ortega et al., 2010), we explored, in both PF and BF T. brucei,
its steady state protein level, the assembly of the complex, and
whether its depletion elicits a reduced growth rate. First, we
determined the steady state levels of a speciﬁc subunit of the SDH
complex, SDH1, which contains the cofactor FAD and is responsible
for the electron entry into the complex. When mitochondrial lysate
was fractionated on a TGX stain-free precast gel followed by
western blot analysis using anti-SDH1 antibody, the correct size
band for SDH1 (66 kDa) was detected. The highest level of
expression is seen in PF cells and much lower amounts of SDH1
subunit are detected in BF cells (Fig. 5A, upper panel). Equal loading
of protein samples was veriﬁed by UV detection of proteins (Fig. 5A,
lower panel). Independently-generated mitochondrial samples
were analysed repeatedly with similar results, conﬁrming the
relatively low intensity of the SDH1 signal in BF cells compared to
PF, and clearly show a much lower steady-state SDH1 protein level
in the former life cycle stage.
To gain better insight about the signiﬁcance of the function of
the SDH complex in PF and BF cells, the level of assembled SDH
complex was analysed by high resolution clear native (hrCNE)
PAGE. The expected band of ~500 kDa (Acestor et al., 2011) is
prominent in the PF sample, but only a very faint band is detected in
BF mitochondrial lysate (Fig. 5B), which correlates well with the
Fig. 3. Cell cycle analysis of BF T. b. brucei. (A) Control culture grown under standard conditions (blue closed symbols) or in the presence of 0.7 mM CD38 analysed for DNA content
(red open symbols). Percentages of cells in each cell cycle stage were determined after staining of the permeabilised cells with propidium iodide, followed by ﬂow cytometry. The
data was further analysed by using the ModFit LT software to accurately separate and quantity the different peaks. (B) Identical culture grown in parallel but in the presence of
0.7 mM AHI-9 (green open symbols). The same control data as in panel A is shown for easy comparison. Panel C shows the cell densities of the cultures in panels A and B during this
experiment, measured by using microscopic cell counts, performed in triplicate, using a haemocytometer. The results shown in panel AeC are the average of three independent
experiments. Error bars depict standard errors, when not shown fall into the symbol. Statistical signiﬁcance was determined using Student's unpaired T-test against the corre-
sponding control group (*P < 0.05, **P < 0.01, ***P < 0.001). D. Percentage of the T. brucei population in each stage of the cell division cycle, with and without incubation with 0.7 mM
CD38 over 24 h, as determined by ﬂuorescence microscopy after staining with DAPI. For each culture, about 500 cells were counted and scored in terms of nuclei and kinetoplasts.
N ¼ nuclei, K ¼ kinetoplasts, E ¼ early stage of division, L ¼ late stage of division (furrow ingression). Signiﬁcant differences from the drug free control were calculated by using the
Chi-squared test. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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T. brucei. Interestingly, two bands were detected in the PF sample,
suggesting that the complex may form higher molecular weight
aggregates, or associate with another macromolecular structure, as
suggested by Kovarova et al. for the mammalian complex II
(Kovarova et al., 2013).
The activity of the SDH complex can be followed spectropho-
tometrically as a change in the absorbance of DCIP, with electrons
ﬂowing from succinate to DCIP via ubiquinone Q2. Each cell linewas
also incubated with the speciﬁc SDH inhibitor malonate to verify
that only this speciﬁc activity was detected. The succinate-
ubiquinone reductase (SQR) activity measured in BF cells corre-
sponded to only 7% of the activity of SQR measured in PF cells
(Table 2). These data closely correspond with the relative steady
state protein levels of SDH complex (see above), and conﬁrm that
the SDH complex is muchmore abundant and is thus likely to play a
more important role in the mitochondria of PF than BF cells.
It has been shown that the SDH complex possesses an essential
function in PF T. brucei (strain EATRO1125) when grown in the
absence of glucose, while its function was unimportant for cellsgrown in the presence of glucose (Coustou et al., 2008). Never-
theless, both tested compounds exert a cytotoxic effect for PF 427
Lister strain T. brucei grown in the presence of glucose (Table 1). To
address whether the SDH complex is essential for the viability of
this speciﬁc strain of T. brucei, and under the speciﬁc conditions
used in our study, a cell line expressing RNAi targeting the SDH1
subunit was generated. When PF SDH1 RNAi cells were grown in
glucose-rich media, no signiﬁcant difference in growth of non-
induced and tetracycline-induced RNA cells was observed.
(Fig. 5C) conﬁrming that the SDH complex is not essential for PF
cells under glucose-rich growth conditions. To test whether the
SDH complex is important for the viability of BF T. brucei cells, the
BF SDH RNAi cell line was examined upon induction with tetracy-
cline. Importantly, there was no growth phenotype at all (Fig. 5D).
To verify successful depletion of SDH1 protein in the PF and BF RNAi
induced cell lines, a western blot analysis was performed with the
speciﬁc SDH1 antibody. In PF RNAi tetracycline-induced cells a
band of the appropriate size had disappeared after 1 day, but a band
of somewhat lower apparent weight remained unchanged (Fig. 5E).
In order to conﬁrm that the upper band was speciﬁc for SDH1, the
Fig. 4. Effects of bisphosphonium compounds on mitochondrial functionality in live BF trypanosomes. (A) Dose-dependency of effect of CD38 and AHI-9 on mitochondrial
membrane potential Jm after four hours of exposure, measured by ﬂow cytometry using the indicator ﬂuorophore TMRE. Data are the triplicate and SEM of three independent
experiments. Statistical signiﬁcance was determined using an unpaired Student's t-test: **, P < 0.01; ***, P < 0.001. (B) Effects of 0.7 mM CD38 and AHI-9 onJm over a period of 8 h,
using 0.1 mM valinomycin and 10 mM troglitazone as controls for membrane depolarisation and hyperpolarisation, respectively. Data are the triplicate and SEM of three independent
experiments. Statistically signiﬁcant differences were observed for CD38 (P < 0.05, 30 min; P < 0.01, 4 h; P < 0.001, 8 and 12 h) and for AHI-9 (P < 0.001 for 4, 8 and 12 h). (C) The
effects of 0.7 mM CD38 or AHI-9 on the total cellular ATP content. Oligomycin (2 mg/mL) was used as positive control and was signiﬁcantly different from untreated controls at all
time points (P < 0.01) whereas the bisphosphonium compounds only induced signiﬁcantly reduced ATP levels at 60 min (P < 0.01). All data are the average and SEM of 3e4
independent experiments. (D) Assessment of intracellular calcium levels using the Fluo-8 indicator dye. Data are presented as percentage of the ﬂuorescence level at time ¼ 0 h for
the untreated control cells. Fluorescence was signiﬁcantly increased after treatment with 0.7 mM CD38 (P < 0.05, 8 h; P < 0.01, 12 h) or AHI-9 ((P < 0.05, 8 and 12 h). Average and
SEM of three independent experiments.
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which led to the reappearance of the upper band within 48 h. In BF
SDH1 RNAi cells, a single distinct band of the expected size was
observed in non-induced cells (N), but this band was undetectable
after just 24 h of RNAi induction (Fig. 5F). Furthermore, the speciﬁc
SQR activity of SDH complex in PF RNAi SDH1 cell line was
decreased by 62% after 1 day of RNAi induction, and almost
completely absent by day 3 (Table 3).
The mitochondrial membrane potential in BF cells is maintained
exclusively by the hydrolytic activity of the FoF1 ATPase complex
(Schnaufer et al., 2005; Subrtova et al., 2015), while in PF cells the
proton motive force is generated by the respiratory chain com-
plexes (Gnipova et al., 2012; Horvath et al., 2005). In order to
determine whether the depletion of SDH complex has any effect on
the mitochondrial membrane potential in PF cells, the electro-
chemical gradient was measured using a ﬂow cytometry analysis
with the dye TMRE that accumulates only in charged mitochondria.
The membrane potential remained unchanged after even 5 days of
RNAi induction (Fig. 5G) indicating that the SDH complex does not
signiﬁcantly contribute to Jm in PF T. brucei cells.
3.4. The effects of bisphosphonium compounds on mitochondrial
ATPases
The reductions in Jm and cellular ATP levels are the early ef-
fects seen after the treatment of T. brucei with bisphosphonium
compounds (see above). However, we here show that, in T. brucei,
the SDH complex is not essential and does not contribute to themembrane potential. It seems therefore unlikely that the principal
trypanocidal activity of bisphosphonium salts would be on this
complex and we thus explored other potential mitochondrial tar-
gets - in particular, the FoF1 ATPase complex that maintains Jm in
BF cells.
First, in vitro ATPase assays were performed using a puriﬁed
mitochondrial fraction, which was lysed by digitonin. The prepared
lysed mitochondrion-enriched fractions from PF cells were treated
with various concentrations of CD38 (Fig. 6A) or AHI-9 (Fig. 6B).
Since there are many ATPases in these samples, the fractions were
also treated with the F1-ATPase inhibitor azide. Typically, 1 mM
azide inhibits 30e40% of all measured ATP hydrolysis activity in
such samples (Zikova et al., 2009). Increasing concentrations of
either drug elicited a similar (CD38) or identical (AHI-9) level of
inhibition as the azide control, albeit at much higher concentra-
tions than their measured EC50 values. These inﬂated concentra-
tions might be an artifact of the in vitro assay performed on lysed
instead of intact and charged mitochondria, as the latter would be
able to concentrate the drugs, driven byJm. Importantly, the same
level of inhibitionwas observedwhen the crudemitochondriawere
treated with azide together with a bisphosphonium salt, indicating
that the inhibitions were not additive and both inhibitors were
therefore acting on the same target. Furthermore, the enzymatic
activity was more strongly affected by AHI-9, which typically has a
stronger effect on trypanosome cells than CD38.
To further evaluate the mechanism of action of bisphosphonium
salts, we determined whether these compounds also affect the rate
of ATP synthesis by FoF1-ATP synthase. This experimental set-up
Fig. 5. Abundance and essentiality of SDH complex in PF and BF cells. A. Steady state abundance of SDH1 subunit in PF and BF cells. Mitochondria were isolated from equal numbers
of cells from T. brucei PF and BF. For each sample 50 mg of protein was loaded onto a BioRad TGX stain-free precast gel. After transfer to a PVDF membrane, the blot was probed with a
rabbit antibody raised against a peptide of T. brucei SDH1. The 50 kDa unknown protein visualized using UV light served as a loading control. B. Relative levels of assembled SDH
complex in PF and BF cells. For each sample 50 mg of mitochondrial protein was loaded onto a high resolution clear native (hrCN) PAGE, which was blotted and probed with the anti-
SDH1 peptide antibody. C. Growth curve of the PF SDH1 RNAi cell line. PF 29.13 cells were transfected with a linearized p2T7-177 vector containing a 485bp fragment of the SDH1
cds. The resulting clonal transfectants were then analysed for a growth phenotype when RNAi was induced with 1 mg/mL tetracycline. These growth curves are representative of
several clones. NON, non-induced cells; IND, induced cells. D. Growth curve of BF SDH1 RNAi. BF T. brucei SM cells were transfected with the same p2T7-177 plasmid and the growth
curve analysis was performed as in C. E. Western blot analysis of PF SDH1 RNAi cells. Whole cell lysates made from equal amounts of cells after the indicated of tetracycline
induction, and loaded onto a 12% SDS PAGE gel. After transfer, the PVDF membrane was probed with the anti-SDH1 antibody. To conﬁrm that the upper of the two bands was
speciﬁc for SDH1, the tetracycline was washed out (-tet) and the reappearance of the upper band was observed within 48 h (-tet, day 5). F. Western blot analysis of BF SDH1 RNAi
cells. Mitochondrial lysate from noninduced (N) cells and cells induced by tetracycline (þtet) for 1 and 3 days were analysed. G. Mitochondrial membrane potential in PF T. brucei
expressing RNAi against SDH1. Units indicated are arbitrary units of TMRE-associated ﬂuorescence. NON, non-induced RNAi cells; Day 1, Day 3, Day 5, signiﬁes the time in days after
RNAi induction. The protonophore FCCP was included as a positive control to indicate the level of ﬂuorescence in cells with depolarised mitochondrial membranes; ﬂuorescence in
FCCP-treated cells was highly signiﬁcantly different from all other test groups. ***, P < 0.001, unpaired Student's t-test, n ¼ 5.
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pathway and is performed with intact, charged mitochondria iso-
lated from PF cells (Allemann and Schneider, 2000). Malonate and
atractyloside are used as positive controls, as the former inhibits
the succinate dehydrogenase complex (i.e. the entry of the elec-
trons), and the latter inhibits the ATP/ADP carrier (i.e. the supplierof the substrate). Not surprisingly, the results indicated that both
CD38 and AHI-9 dose-dependently inhibited ATP production in
intact T. brucei mitochondria, with concentrations similar to the
measured EC50 values moderately inhibitory and higher concen-
trations inhibiting ATP production almost completely (Fig. 7).
While this assay does not rule out succinate dehydrogenase as a
Table 2
SQR activity in intact PF427 and BF427 Trypanosoma brucei.
Cells SDH speciﬁc activity (Ua/mg) ± SEMb % of PF activity % of effect of malonate
PF 427 1.2 ± 0.011 100 100
PF 427 þ mal 0.21 ± 0.006 17
BF 427 0.084 ± 0.007 7 100
BF 427 þ mal 0.0381 ± 0.002 45
SQR activity in PF and BF T. brucei cells was measured spectrophotometrically as described in the methods section, in the presence or absence of 1 mM malonate (mal).
a The unit (U) of SQR is deﬁned as the amount of enzyme required for the conversion of 1 nmol of 2,6-dichlorophenolindophenol/min/mg of mitochondrial proteins.
b Each measurement was performed in triplicate.
Table 3
SQR activity in PF RNAi SDH1 noninduced (N) and tetracycline induced (þtet) cells in the presence of absence of malonate (mal).
Cells SDH speciﬁc activity (Ua/mg) ± SEMb % of 29e13 activity % of RNAi N activity
PF 29-13 0.658 ± 0.021 100
PF 29-13 þ mal 0.156 ± 0.004 24
PF RNAi Sdh1 N 0.497 ± 0.005 100
PF RNAi Sdh1 N/þmal 0.107 ± 0.008 22
PF RNAi Sdh1 1d þtet 0.19 ± 0.0046 38
PF RNAi Sdh1 3d þtet 0.08 ± 0.005 16
a The unit (U) of SQR is deﬁned as an amount of enzyme required for conversion of 1 nmol of 2,6-dichlorophenolindophenol/min/mg of mitochondrial proteins.
b Each measurement was performed in triplicate.
Fig. 6. ATPase activity of mitochondrion-enriched fractions of PF427 treated with CD38 (A) and AHI-9 (B). Approximately 15 mg of hypotonically isolated mitochondria were
incubated with the indicated test compounds for 5 min and then transferred to ATPase assay buffer. Changes in NADH absorbance were monitored at 340 nm for 5 min. Speciﬁc
ATPase activity from mitochondrial lysates was calculated from the amount of oxidized NADH per minute, and related to the amount of total protein. The speciﬁc ATPase activity in
the non-induced sample was set at 100%. Assays were performed in triplicate. Error bars depict standard errors of the mean. Statistical signiﬁcance was determined using Student's
unpaired T-test.
Fig. 7. Effect of CD38 (A) and AHI-9 (B) treatment on ATP production in PF mitochondria. Crude mitochondrial preparations were obtained by digitonin extraction and ATP
production in untreated and treated samples was measured using succinate as a substrate. Malonate, speciﬁc inhibitor of succinate dehydrogenase was used to inhibit ATP pro-
duction by oxidative phosphorylation and atractyloside was used to inhibit import of ADP into mitochondria. ATP production in untreated mitochondria was set to 100%. The bars
represent means expressed as percentages from three independent RNAi inductions. Error bars are SEM.
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an active mitochondrialJm is important to these in vitro assays, as
the test compounds were much more active than on mitochondrial
lysates.
Since the effects on total mitochondrial ATP hydrolytic and ATP
synthetic activities were indicative of speciﬁc inhibition of the FoF1
ATP synthase/ATPase, we repeated the assay on highly puriﬁed F1-
ATPase, and observed a similar dose dependency of inhibition as
above on the lysed mitochondrial fractions, i.e. less potent than in
intact and charged mitochondria. In this experiment, azide inhibits
almost 100% of the activity of the puriﬁed F1-ATPase, conﬁrming
the purity of the sample. The increasing concentrations of the
bisphosphonium test compounds reduced the ATP hydrolysis ac-
tivity in a linearmanner. Once again, AHI-9 displayed a signiﬁcantly
higher level of inhibition than CD38. In fact, 200 mM AHI-9 inacti-
vated F1-ATPase almost to the same extent as azide (Fig. 8). We
conclude that inhibition of the F1-ATPase is at a minimum an
important contributing factor in the mechanism of action of
bisphosphonium compounds on T. brucei.4. Discussion
The phosphonium salts were discovered as potent chemother-
apeutics against Trypanosoma cruzi and T. b. rhodesiense in the late
1970s (Kinnamon et al., 1977, 1979). Thirty years later
benzophenone-derived bisphosphonium salts were synthesized
showing much higher potency against Leishmania parasites. Some
of these phosphonium derivatives act as lipophilic cations with
enhanced hydrophobicity that allow them to cross biological
membranes and accumulate in organelles with a strong electro-
chemical gradient, e.g. mitochondria. Interestingly, in mammalian
cells, these lipophilic phosphonium ions are being developed to
deliver antioxidants or anti-cancer drugs to mitochondria as they
pass easily through the lipid bilayers. Because of their disperse
charged the electrochemical gradient drives their accumulation
into the mitochondrial matrix concentrating them as high as
100e500 fold (Murphy, 2008).
The nature of the trypanocidal activity of these compounds has
not been determined yet, but in L. donovani some bisphosphonium
compounds including CD38 were shown to have a negative impact
on proper mitochondrial function (Luque-Ortega et al., 2010). Upon
treatment with a low drug concentration (0.7 mM) the mitochon-
dria were swollen, the mitochondrial Jm was signiﬁcantly
decreased, the oxygen consumption rate, using succinate as a
substrate, was affected, and the cellular ATP levels were reduced.
These results would suggest that the drug was either affecting aFig. 8. Activity of T. brucei puriﬁed F1-ATPase treated with CD38 (A) and AHI-9 (B). ATPase a
standard errors of mean.component of the oxidative phosphorylation pathway, or was
acting as a kind of ionophore or charge carrier, depolarizing the
mitochondrial membrane. The study proposed that in L. donovani
the bisphosphonium compounds act through inhibition of the
respiratory complex II, succinate dehydrogenase (Luque-Ortega
et al., 2010).
While the available data certainly suggest that CD38 might be
able to inhibit succinate dehydrogenase in Leishmania, it seems
unlikely that this would be the mode of action for bisphosphonium
drugs in T. brucei. Since metabolic activities of BF mitochondria are
largely repressed with the exception of lipid metabolism (Guler
et al., 2008), ion homeostasis (Nolan and Voorheis, 1992), calcium
signalling (Huang et al., 2013; Vercesi et al., 1992), FeS cluster as-
sembly (Kovarova et al., 2014) and acetate production for de novo
lipid biosynthesis (Mazet et al., 2013), it is generally assumed that
succinate dehydrogenase complex is largely inactive and unim-
portant for these cells. Therefore, we decided to investigate how
bisphosphonium salts interact with the unique metabolism of BF
trypanosomes.
We found that adding CD38 and AHI-9, at concentrations close
to their trypanocidal EC50 values, into the T. brucei culture prevents
the initiation and replication of kDNA, reduces cellular ATP levels,
and depolarizes the mitochondrial membrane potential within a
few hours of treatment; this was immediately followed by
increased cytosolic Ca2þ levels. All these phenotypic changes point
also to a mitochondrial target, although not necessarily to succinate
dehydrogenase. Succinate dehydrogenase does not directly
contribute to the membrane potential by pumping protons, as it
passes its electrons to ubiquinone. Moreover, we show that in BF it
is not essential, as RNAi knockdown presented no growth pheno-
type, and indeed succinate dehydrogenase is barely present as an
assembled complex in this life-cycle stage. Furthermore, the suc-
cinate dehydrogenase complex is also not essential for PF T. brucei
grown under high glucose conditions (this work and (Coustou et al.,
2008)) and does not contribute to the mitochondrial membrane
potential e yet, both of the tested drugs have a strong effect against
PF cells (EC50 values in single digit mM range) and decreased the
mitochondrial Jm. We thus conclude that, in trypanosomes, in-
hibition of succinate dehydrogenase is not mode of action of the
bisphosphonium compounds.
Interestingly, the potent trypanocidal diamidine DB75 induces a
similar phenotype in BF cells, as its treatment collapses the mito-
chondrial Jm and inhibits glucose-dependent cellular respiration,
apparently through inhibition of the hydrolytic function of FoF1
ATPase (Lanteri et al., 2008), which, in BF cells, employs its reverse
function in order to maintain the mitochondrial Jm (Schnauferctivity was measured as described in the legend to Fig. 6, in triplicate. Error bars depict
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overlap with those of the speciﬁc FoF1 ATPase inhibitor oligomycin,
which decreases mitochondrial membrane potential, inhibits oxy-
gen consumption and reduces cellular ATP levels by 50% (Nolan and
Voorheis, 1992). We observed similarly reduced cellular ATP levels
upon treatment with the bisphosphonium compounds CD38 and
AHI-9. The observed reduction in ATP is consistent with inhibition
of the FoF1 complex, which is followed by immediate mitochondrial
membrane depolarization, as in BF cells respiration through alter-
native oxidase is sensitive to Jm dissipation (Miller and Klein,
1980). The membrane depolarization in turn results in the loss of
the glycerol-3-phosphate shuttle and the subsequent redirection of
glycolysis to 1 molecule of glycerol and 1 molecular of pyruvate.
Thus, pyruvate production falls by 50% upon oligomycin treatment
(Nolan and Voorheis, 1992) and only 1 molecule of ATP is made
from 1 molecule of glucose. Similarly, we report an approximately
50% reduction in cellular ATP concentration upon treatment with
bisphosphonium drugs.
Moreover, our data strongly suggest that bisphosphonium salts
CD38 and AHI-9 inhibit the hydrolytic activity of the FoF1 ATPase
in vitro. Inhibition assays, performed onmitochondrial lysates from
PF cells and on highly puriﬁed F1-ATPase, showed highly signiﬁcant
inhibition of ATPase activity to similar levels as achievedwith 1mM
azide. AHI-9, particularly, inhibited the isolated F1 ATPase almost
completely. Furthermore, a combination of azide plus CD38 or AHI-
9 did not result in additional inhibition of ATPase activity compared
to either drug separately, suggesting that no other mitochondrial
ATPases play a signiﬁcant role in the observed phenotype.
Interestingly, all the biochemical analyses performed revealed a
greater sensitivity to AHI-9 than to CD38, which correlates nicely
with the almost 4-fold lower EC50 value for the former compound.
It should be noted that the in vitro assay, which measured ATPase
activity in lysates, required concentration of the compounds that
are considerably higher than the EC50 values, as the lipophilic
cations greatly concentrate in the mitochondrion (Murphy, 2008),
because Jm creates a negative charge in the matrix. This
assumption is completely consistent with our results from the ATP
production assay, which utilizes intact and charged mitochondria
from PF cells. In this assay, ATP production was inhibited by the
bisphosphonium compounds at the concentration similar to EC50
values.
The reduction in cellular ATP levels may be the immediate cause
of the observed failure in initiating the S-phase of the cell cycle
(DNA synthesis). Trypanosomatid kDNA is a highly organized
structure composed of thousands of minicircles and tens of max-
icircles (Liu et al., 2005). To ensure that daughter cells receive
completely identical kDNA networks, the replication process is
highly synchronized with nuclear replication followed by cell di-
vision (Jensen and Englund, 2012). kDNA replication relies on ATP
and hundreds of mitochondrial proteins (Beck et al., 2013), which
are imported to mitochondria via the Jm-dependent TIM ma-
chinery (Williams et al., 2008). Thus it is plausible to speculate that
a lack of ATP and decrease of Jm will interfere with proper initi-
ation of kDNA replication and result in cell cycle arrest. Similar
results were observed upon RNAi knock-down of the ATP/ADP
carrier in PF T. brucei cells, inwhich reduced ATP levels led to failure
of the overall cell division machinery (Gnipova et al., 2015). In
contrast, a direct inhibition by bisphosphonium salts of kDNA
replication, segregation and maintenance as their primary mode of
action is far less likely, as (i) these compounds have a poor afﬁnity
to DNA as shown previously (Dardonville et al., 2006) and in this
study, (ii) CD38 and AHI-9 cause a decrease inJm in T. brucei cells
that lack mitochondrial DNA (Gould, Schnaufer and De Koning,
unpublished), and (iii) interference with kDNA replication, either
by RNAi or drug treatment, usually leads to complete loss of kDNA(Bruhn et al., 2011; Hiltensperger et al., 2012; Tyc et al., 2015).
In conclusion, our data strongly suggest that bisphosphonium
compounds CD38 and AHI-9 primarily act on trypanosomes
through inhibition of the F1-ATPase although additional mito-
chondrial targets cannot be excluded.
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